News
Multivitamin supplements may reduce cancer risk
18 October 2012
According to a new US study, a daily intake of a combination of low-dose vitamins and minerals can decrease total cancer incidence by 8%.
20 January 2014
New studies from Sweden report that low intakes and low serum concentrations of vitamin E seem to be associated with an increased rate of fracture in older women and men.
In two cohort studies, the vitamin E (alpha-tocopherol) intakes and blood concentrations of 61,433 women and 1138 men were measured and cases of fractures were documented over a period of 19 years (1). The studies’ results showed that women and men with the lowest intakes and/or blood levels of vitamin E had a significantly higher risk for hip fractures, as well as any other fractures.
The researchers commented that a reduction in the formation of free radicals and oxidative stress might reduce the rate of bone loss and muscle wasting in the elderly. Because vitamin E has high levels of anti- oxidant activity, it may favorably influence bone and muscle mass (2, 3). However, there are few human studies on the effect of alpha-tocopherol in relation to bone health. Osteoporotic fractures constitute a large and growing problem worldwide in both women and men, which have a profound effect on quality of life and mortality. Fracture risk is influenced by both genetic constitution and by environmental factors. Lifestyle factors (e.g., diet and physical activity) also gain importance with increasing age.
18 October 2012
According to a new US study, a daily intake of a combination of low-dose vitamins and minerals can decrease total cancer incidence by 8%.
1 March 2009
“On March 10, 2009, a summary of a study was published which reports a higher incidence of prostate cancer after several years’ (up to 10.8 years, median 7 years) intake of folic acid.
14 March 2016
According to a new report the voluntary additions of micronutrients to foods in Ireland have made a favorable nutritional impact on the diets of adults and have not contributed to an increased risk of adverse effects.